Literature DB >> 18291707

Intracameral SF6 injection and anterior segment OCT-based documentation for acute hydrops management in pellucid marginal corneal degeneration.

M Vanathi1, Geeta Behera, Sujith Vengayil, Anita Panda, S Khokhar.   

Abstract

PURPOSE: To report a case of acute hydrops in pellucid marginal corneal degeneration (PMCD) documented with anterior segment optical segment tomography and successfully treated with sulphur hexafluoride (SF6) intracameral injection.
METHODS: A 47-year-old female patient presented with spontaneous onset of pain, redness and decreased vision in her left eye. Clinical evaluation revealed bilateral PMCD with evidence of acute hydrops in the left eye. Anterior segment Slit lamp Adapted Optical Coherence Tomography (SL-OCT) examination revealed intrastromal clefts with Descemet's membrane detachment in the left eye. She was managed with descemetopexy with 0.2ml injection of iso-expansile SF6 (18%) intracameral.
RESULTS: The patient showed excellent early resolution of the stromal edema with reattachment of the Descemet's membrane.
CONCLUSION: Prompt intervention in acute hydrops in PMCD cases helps in achieving early good visual results and prevents potentially serious complications such as perforation. Newer imaging modalities like SL-OCT helps in better visualisation and also in monitoring the response to treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18291707     DOI: 10.1016/j.clae.2008.01.001

Source DB:  PubMed          Journal:  Cont Lens Anterior Eye        ISSN: 1367-0484            Impact factor:   3.077


  2 in total

1.  Different compression sutures combined with intracameral air injection for acute corneal hydrops.

Authors:  Xin Liu; Hua Li; Shen Qu; Qiao Yu; Hui Lin; Yan-Long Bi
Journal:  Int J Ophthalmol       Date:  2022-09-18       Impact factor: 1.645

Review 2.  Applications of Anterior Segment Optical Coherence Tomography in Cornea and Ocular Surface Diseases.

Authors:  Sang Beom Han; Yu-Chi Liu; Karim Mohamed Noriega; Jodhbir S Mehta
Journal:  J Ophthalmol       Date:  2016-09-19       Impact factor: 1.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.